No abstract available
Publication types
-
Consensus Development Conference
MeSH terms
-
Advisory Committees
-
American Heart Association
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / epidemiology*
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Myocardial Infarction / epidemiology*
-
Prevalence
-
Risk Factors
-
Rosiglitazone
-
Thiazolidinediones / adverse effects*
-
United States / epidemiology
Substances
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Rosiglitazone